Biomatrix (BXM) Looking Great Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biomatrix (BXM) Looking Great

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: John McCarthy who wrote (162)	11/2/1997 10:53:00 PM
From: pkwknk	Read Replies (1) of 569

...spoke to a few busy orthopods who say the knee-injection mkt is very big...these guys do at least 20-30/wk with steroids which are short term and not particularly satisfying...injection takes less than a minute...if MD is paid per injection and possibly for visit(s), it provides a good incentive, and with managed care/medicare a good alternative to surgery....I see a big point being the following --- since sales will be done directly to MD, does he have to expend/risk capital for inventory, or will payor have a relationship which bypasses that need? this could be a big point, especially at $500 a pop!!!t.... I was also told by a rheumatologist that as recently as 2 months ago the Am coll of Rheum ( unconfirmed, just what he said) stated that synvisc was no better than tylenol as an analgesicl...since the college's convention is I believe next weekend, that should be clarified...combination of a big market, an apparently effective product with little major competition, and a great sales force in Wyeth Arest makes this very compelling...

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next